565 related articles for article (PubMed ID: 33024120)
1. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).
Zhang Y; Gu Y; Ren H; Wang S; Zhong H; Zhao X; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Kong P; Hou G; Gao M; Shi Z; Li X; Qiu Y; Zou Y; Yang H; Wang J; Xu G; Lai S; Li J; Ning G; Wang W
Nat Commun; 2020 Oct; 11(1):5015. PubMed ID: 33024120
[TBL] [Abstract][Full Text] [Related]
2. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.
Wang S; Ren H; Zhong H; Zhao X; Li C; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Zou Y; Shi Z; Li X; Li T; Yang H; Lai S; Xu G; Li J; Zhang Y; Gu Y; Wang W
Gut Microbes; 2022; 14(1):2003176. PubMed ID: 34923903
[TBL] [Abstract][Full Text] [Related]
3. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study.
Ming J; Yu X; Xu X; Wang L; Ding C; Wang Z; Xie X; Li S; Yang W; Luo S; He Q; Du Y; Tian Z; Gao X; Ma K; Fang Y; Li C; Zhao J; Wang X; Ji Q
Genome Med; 2021 Aug; 13(1):125. PubMed ID: 34365978
[TBL] [Abstract][Full Text] [Related]
5. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
[TBL] [Abstract][Full Text] [Related]
6. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
Zhang W; Xu JH; Yu T; Chen QK
Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
[TBL] [Abstract][Full Text] [Related]
9. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
[TBL] [Abstract][Full Text] [Related]
10. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Berberine and Probiotics (
Huang C; Sun Y; Liao SR; Chen ZX; Lin HF; Shen WZ
Front Microbiol; 2022; 13():869931. PubMed ID: 35572672
[TBL] [Abstract][Full Text] [Related]
12. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
13. Modulating gut microbiota as an anti-diabetic mechanism of berberine.
Han J; Lin H; Huang W
Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646
[TBL] [Abstract][Full Text] [Related]
14. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
15. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
[TBL] [Abstract][Full Text] [Related]
16. Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial.
Zhang R; Xiao Y; Yan J; Yang W; Wu X; Mei Z; Zhou Z
Front Endocrinol (Lausanne); 2022; 13():876657. PubMed ID: 35784546
[TBL] [Abstract][Full Text] [Related]
17. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
18. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
19. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
[TBL] [Abstract][Full Text] [Related]
20. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
